Total Internal Biliary Diversion for Post-Liver Transplant PFIC-1-Related Allograft Injury

Naresh Shanmugam1, Jagadeesh Menon1, Mukul Vij1

  • 1The Institute of Liver Disease & Transplantation, Dr. Rela Institute & Medical Centre, Bharath Institute of Higher Education & Research, Chennai, India.

Insights

Progressive familial intrahepatic cholestasis type 1 (PFIC-1) complications after liver transplantation (LT), including steatohepatitis and diarrhea, can be effectively managed. Total internal biliary diversion offers a safe solution for these challenging post-transplant conditions.

Area of Science:

  • Hepatology
  • Pediatric Gastroenterology
  • Transplantation Surgery

Background:

  • Progressive familial intrahepatic cholestasis type 1 (PFIC-1) often leads to complications like steatohepatitis and refractory diarrhea in children post-liver transplantation (LT).
  • Standard medical management, including bile acid binders, is frequently insufficient, potentially leading to allograft dysfunction and loss.

Observation:

  • A 7-year-old boy with PFIC-1 experienced worsening liver function, steatohepatitis, and intractable diarrhea 5 years after LT.
  • Conventional therapies failed to resolve these progressive post-transplant complications.

Findings:

  • A total internal biliary diversion was performed to interrupt the enterohepatic circulation, resolving the patient's refractory diarrhea and normalizing transaminases.
  • Follow-up liver biopsy after one year demonstrated complete resolution of steatohepatitis, with sustained clinical improvement and weight gain at 18 months.

Implications:

  • Total internal biliary diversion is a safe and effective therapeutic option for managing severe post-LT complications, specifically allograft injury secondary to PFIC-1 pathology.
  • This surgical approach offers a promising strategy to improve outcomes and prevent graft loss in pediatric liver transplant recipients with PFIC-1.

Related Concept Videos